IRIS - Res&Arch Institutional Research Information System - Research & Archive

PORCELLATI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.901
EU - Europa 2.439
AS - Asia 1.910
SA - Sud America 323
AF - Africa 35
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.631
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.848
SG - Singapore 950
IT - Italia 400
IE - Irlanda 385
SE - Svezia 346
CN - Cina 317
UA - Ucraina 314
BR - Brasile 290
RU - Federazione Russa 274
HK - Hong Kong 269
DE - Germania 228
VN - Vietnam 171
FI - Finlandia 152
GB - Regno Unito 99
FR - Francia 67
KR - Corea 58
AT - Austria 36
PL - Polonia 35
CA - Canada 27
TR - Turchia 25
IN - India 24
CZ - Repubblica Ceca 19
JP - Giappone 18
NL - Olanda 18
AU - Australia 16
MX - Messico 16
ZA - Sudafrica 16
BE - Belgio 13
UZ - Uzbekistan 13
CH - Svizzera 12
ES - Italia 12
BD - Bangladesh 11
AR - Argentina 10
IQ - Iraq 10
RO - Romania 6
EC - Ecuador 5
ID - Indonesia 5
LT - Lituania 5
PE - Perù 5
GR - Grecia 4
IL - Israele 4
JO - Giordania 4
NP - Nepal 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CO - Colombia 3
EG - Egitto 3
EU - Europa 3
LB - Libano 3
MA - Marocco 3
PH - Filippine 3
PK - Pakistan 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
VE - Venezuela 3
BO - Bolivia 2
BW - Botswana 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
KE - Kenya 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NE - Niger 1
NG - Nigeria 1
PA - Panama 1
PY - Paraguay 1
SI - Slovenia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 7.631
Salva come PNG Salva come JPEG
Città #
Singapore 631
Chandler 474
Dublin 385
Hong Kong 267
San Mateo 224
Boardman 174
Jacksonville 160
Ashburn 140
Santa Clara 127
Altamura 112
Medford 109
Princeton 109
Munich 93
Wilmington 92
Perugia 91
Moscow 84
Beijing 80
Lawrence 80
Ann Arbor 79
Dong Ket 76
Seoul 58
Andover 53
Los Angeles 50
New York 50
Helsinki 49
Rome 40
Des Moines 38
Ho Chi Minh City 31
Saint Petersburg 27
Brooklyn 25
Piscataway 24
Frankfurt am Main 23
Woodbridge 23
Chicago 22
Warsaw 22
Norwalk 21
Nuremberg 21
São Paulo 21
Falls Church 20
Turku 20
Milan 17
Hanoi 16
Amelia 15
Vienna 15
Brno 14
Izmir 13
Tokyo 13
Brussels 12
Falkenstein 12
Amsterdam 11
Stockholm 11
London 10
San Francisco 10
The Dalles 10
Orem 9
Poplar 9
Porto Alegre 9
Bexley 8
Boston 8
Denver 8
San Paolo di Civitate 8
Ankara 7
Atlanta 7
Auburn Hills 7
Belo Horizonte 7
Johannesburg 7
Montreal 7
Mumbai 7
Redmond 7
Columbus 6
Curitiba 6
Dhaka 6
Fremont 6
Guangzhou 6
Houston 6
Melbourne 6
Mexico City 6
Rio de Janeiro 6
Tashkent 6
Toronto 6
Bolton 5
Bucu 5
Changsha 5
Dallas 5
Goiânia 5
Hải Dương 5
Ottawa 5
Phoenix 5
Shanghai 5
Amman 4
Athens 4
Brasília 4
Campinas 4
Cardiff 4
Da Nang 4
Durban 4
Florence 4
Lappeenranta 4
Miami 4
Olomouc 4
Totale 4.674
Salva come PNG Salva come JPEG
Nome #
Ipoglicemia da iperinsulinismo organico: un caso di nesidioblastosi dell’adulto. 199
Adrenaline vs glucagon in the primacy of glucose counterregulation 147
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 139
Hypoglycemia 132
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 128
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 108
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 105
EFFECT OF PYRIDOXAL 5'-PHOSPHATE AND VALPROICACID ON PHOSPHOLIPID SYNTHESIS INNEUROBLASTOMA NA 101
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 101
Cognitive function in hypoglycaemia 99
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 99
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 97
A novel surrogate index for hepatic insulin resistance. 97
Administration of Neutral Protamine Hagedorn insulin at bedtime versus dinner in Type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control: a randomized, controlled trial. 97
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 96
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 95
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 91
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 91
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 89
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 89
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. 89
EPIDEMIOLOGICAL SURVEY FOR THE DETECTION OF NON–TRAUMATIC LOWER EXTREMITY AMPUTATIONS IN DIABETIC PATIENTS IN THE UMBRIA REGION (ITALY). 88
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 86
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 85
Awareness, identification and prevention of insulin injection-associated lipodystrophies 85
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study 83
Counterregulatory hormone and symptom responses to insulin-induced hypoglycaemia in the postprandial state in humans 82
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 82
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 82
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 79
Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes. 78
Alternate splicing in human Na+-MI cotransporter gene yelds differentially regulated trasport isoforms 78
Glucagon: the effects of its excess and deficiency on insulin action 77
[Usefulness of plantar pressure measurement for the prevention and treatment of neuropathic diabetic foot]. 77
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 77
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 76
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 76
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 74
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 74
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 72
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 71
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 71
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 71
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 71
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 70
Body composition and common carotid artery remodeling in a healthy population 70
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro 70
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus 68
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin 67
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 66
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? 66
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. 65
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 65
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 65
Quando “i conti non tornano” (Caso clinico) G It Diabetol Metab 26:172-175 64
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 64
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 64
Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. 63
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 63
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 63
Responses to hypoglycemia in diabetic autonomic neuropathy. 62
Insulin therapy and hypoglycemia: the size of the problem 61
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 60
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. 59
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 57
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 57
Obesity and carotid artery remodeling 57
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 57
Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage 56
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 55
The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women 55
Recovery and prevention of hypoglycaemia unawareness in Type 1 diabetes mellitus 55
How to accurately establish pharmacokinetics/ pharmacodynamics of long- Acting insulins in humans: Relevance to biosimilar insulins 54
Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy. 53
Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population 52
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 52
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes mellitus. 51
Pharmacokinetics and pharmacodynamics of basal insulins. 51
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. 51
Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults 51
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 51
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 50
INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS IS DIFFERENT BETWEEN GLUCOSE AND PROTEIN METABOLISM 50
L’insulina biosimilare è “clinicamente uguale” all’originator, ma… 50
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways 50
null 49
Gli Analoghi dell’Insulina ad Azione Ritardo: dalla storia di ieri alle opzioni di oggi 49
Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology 49
Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort 49
Modification and validation of the triglyceride-to-HDL cholesterol ratio as a surrogate of insulin sensitivity in white juveniles and adults without diabetes mellitus: The single point insulin sensitivity estimator (SPISE) 48
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance. 47
Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials 47
From Metabolic Normality to Cardiometabolic Risk Factors in Subjects With Obesity 46
The impact of ideglira in treatment simplification in older adults with type 2 diabetes mellitus already on insulin therapy: The stop study 45
Metabolic effects of an SGLT2 inhibitor (Dapagliflozin) during a period of acute insulin withdrawal and development of ketoacidosis in people with type 1 diabetes. Diabetes care 2020;43:2128– 2136 45
The role of gastric emptying in glucose homeostasis and defense against hypoglycemia: Innocent bystander or partner in crime? 44
Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial 44
Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: a Double-Blind, Randomized, Crossover Study. Response to Banarer. 44
Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemia 44
The physiological basis of insulin therapy in people with diabetes mellitus 43
Totale 7.187
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.022
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021432 0 0 0 0 0 71 49 13 96 37 64 102
2021/2022839 20 156 21 59 20 14 8 271 17 25 102 126
2022/20231.510 116 287 17 126 115 191 2 69 527 6 43 11
2023/2024658 36 76 35 11 5 7 121 2 44 28 147 146
2024/20251.624 25 157 45 98 264 37 61 146 319 108 214 150
2025/20261.662 262 228 187 359 506 120 0 0 0 0 0 0
Totale 7.855